Although Chandramohan et al. [25] recently reported antitumor activity of scFv targeting Aggrus/podoplanin fused with immunotoxin in an intracranial medulloblastoma model using scFv to target the tumor, Aggrus-neutralizing activity of it was not examined. The gene discussed is PDPN; the disease is neoplasm.